Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection.

Farrow AL, Rachakonda G, Gu L, Krendelchtchikova V, Nde PN, Pratap S, Lima MF, Villalta F, Matthews QL. Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection. PLoS Negl Trop Dis. 2014 Aug; 8(8):e3089.

View in: PubMed

subject areas

Adenoviridae
Animals
Capsid Proteins
Chagas Disease
Female
Genetic Vectors
Humans
Mice
Mice, Inbred C57BL
Protozoan Proteins
Trypanosoma cruzi
Variant Surface Glycoproteins, Trypanosoma

authors with profiles

Fernando Villalta
Siddharth Pratap
PIUS NDE

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support